Cargando…
A Comparative Chemogenomics Strategy to Predict Potential Drug Targets in the Metazoan Pathogen, Schistosoma mansoni
Schistosomiasis is a prevalent and chronic helmintic disease in tropical regions. Treatment and control relies on chemotherapy with just one drug, praziquantel and this reliance is of concern should clinically relevant drug resistance emerge and spread. Therefore, to identify potential target protei...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2635471/ https://www.ncbi.nlm.nih.gov/pubmed/19198654 http://dx.doi.org/10.1371/journal.pone.0004413 |
_version_ | 1782164183661412352 |
---|---|
author | Caffrey, Conor R. Rohwer, Andreas Oellien, Frank Marhöfer, Richard J. Braschi, Simon Oliveira, Guilherme McKerrow, James H. Selzer, Paul M. |
author_facet | Caffrey, Conor R. Rohwer, Andreas Oellien, Frank Marhöfer, Richard J. Braschi, Simon Oliveira, Guilherme McKerrow, James H. Selzer, Paul M. |
author_sort | Caffrey, Conor R. |
collection | PubMed |
description | Schistosomiasis is a prevalent and chronic helmintic disease in tropical regions. Treatment and control relies on chemotherapy with just one drug, praziquantel and this reliance is of concern should clinically relevant drug resistance emerge and spread. Therefore, to identify potential target proteins for new avenues of drug discovery we have taken a comparative chemogenomics approach utilizing the putative proteome of Schistosoma mansoni compared to the proteomes of two model organisms, the nematode, Caenorhabditis elegans and the fruitfly, Drosophila melanogaster. Using the genome comparison software Genlight, two separate in silico workflows were implemented to derive a set of parasite proteins for which gene disruption of the orthologs in both the model organisms yielded deleterious phenotypes (e.g., lethal, impairment of motility), i.e., are essential genes/proteins. Of the 67 and 68 sequences generated for each workflow, 63 were identical in both sets, leading to a final set of 72 parasite proteins. All but one of these were expressed in the relevant developmental stages of the parasite infecting humans. Subsequent in depth manual curation of the combined workflow output revealed 57 candidate proteins. Scrutiny of these for ‘druggable’ protein homologs in the literature identified 35 S. mansoni sequences, 18 of which were homologous to proteins with 3D structures including co-crystallized ligands that will allow further structure-based drug design studies. The comparative chemogenomics strategy presented generates a tractable set of S. mansoni proteins for experimental validation as drug targets against this insidious human pathogen. |
format | Text |
id | pubmed-2635471 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-26354712009-02-09 A Comparative Chemogenomics Strategy to Predict Potential Drug Targets in the Metazoan Pathogen, Schistosoma mansoni Caffrey, Conor R. Rohwer, Andreas Oellien, Frank Marhöfer, Richard J. Braschi, Simon Oliveira, Guilherme McKerrow, James H. Selzer, Paul M. PLoS One Research Article Schistosomiasis is a prevalent and chronic helmintic disease in tropical regions. Treatment and control relies on chemotherapy with just one drug, praziquantel and this reliance is of concern should clinically relevant drug resistance emerge and spread. Therefore, to identify potential target proteins for new avenues of drug discovery we have taken a comparative chemogenomics approach utilizing the putative proteome of Schistosoma mansoni compared to the proteomes of two model organisms, the nematode, Caenorhabditis elegans and the fruitfly, Drosophila melanogaster. Using the genome comparison software Genlight, two separate in silico workflows were implemented to derive a set of parasite proteins for which gene disruption of the orthologs in both the model organisms yielded deleterious phenotypes (e.g., lethal, impairment of motility), i.e., are essential genes/proteins. Of the 67 and 68 sequences generated for each workflow, 63 were identical in both sets, leading to a final set of 72 parasite proteins. All but one of these were expressed in the relevant developmental stages of the parasite infecting humans. Subsequent in depth manual curation of the combined workflow output revealed 57 candidate proteins. Scrutiny of these for ‘druggable’ protein homologs in the literature identified 35 S. mansoni sequences, 18 of which were homologous to proteins with 3D structures including co-crystallized ligands that will allow further structure-based drug design studies. The comparative chemogenomics strategy presented generates a tractable set of S. mansoni proteins for experimental validation as drug targets against this insidious human pathogen. Public Library of Science 2009-02-09 /pmc/articles/PMC2635471/ /pubmed/19198654 http://dx.doi.org/10.1371/journal.pone.0004413 Text en Caffrey et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Caffrey, Conor R. Rohwer, Andreas Oellien, Frank Marhöfer, Richard J. Braschi, Simon Oliveira, Guilherme McKerrow, James H. Selzer, Paul M. A Comparative Chemogenomics Strategy to Predict Potential Drug Targets in the Metazoan Pathogen, Schistosoma mansoni |
title | A Comparative Chemogenomics Strategy to Predict Potential Drug Targets in the Metazoan Pathogen, Schistosoma mansoni
|
title_full | A Comparative Chemogenomics Strategy to Predict Potential Drug Targets in the Metazoan Pathogen, Schistosoma mansoni
|
title_fullStr | A Comparative Chemogenomics Strategy to Predict Potential Drug Targets in the Metazoan Pathogen, Schistosoma mansoni
|
title_full_unstemmed | A Comparative Chemogenomics Strategy to Predict Potential Drug Targets in the Metazoan Pathogen, Schistosoma mansoni
|
title_short | A Comparative Chemogenomics Strategy to Predict Potential Drug Targets in the Metazoan Pathogen, Schistosoma mansoni
|
title_sort | comparative chemogenomics strategy to predict potential drug targets in the metazoan pathogen, schistosoma mansoni |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2635471/ https://www.ncbi.nlm.nih.gov/pubmed/19198654 http://dx.doi.org/10.1371/journal.pone.0004413 |
work_keys_str_mv | AT caffreyconorr acomparativechemogenomicsstrategytopredictpotentialdrugtargetsinthemetazoanpathogenschistosomamansoni AT rohwerandreas acomparativechemogenomicsstrategytopredictpotentialdrugtargetsinthemetazoanpathogenschistosomamansoni AT oellienfrank acomparativechemogenomicsstrategytopredictpotentialdrugtargetsinthemetazoanpathogenschistosomamansoni AT marhoferrichardj acomparativechemogenomicsstrategytopredictpotentialdrugtargetsinthemetazoanpathogenschistosomamansoni AT braschisimon acomparativechemogenomicsstrategytopredictpotentialdrugtargetsinthemetazoanpathogenschistosomamansoni AT oliveiraguilherme acomparativechemogenomicsstrategytopredictpotentialdrugtargetsinthemetazoanpathogenschistosomamansoni AT mckerrowjamesh acomparativechemogenomicsstrategytopredictpotentialdrugtargetsinthemetazoanpathogenschistosomamansoni AT selzerpaulm acomparativechemogenomicsstrategytopredictpotentialdrugtargetsinthemetazoanpathogenschistosomamansoni AT caffreyconorr comparativechemogenomicsstrategytopredictpotentialdrugtargetsinthemetazoanpathogenschistosomamansoni AT rohwerandreas comparativechemogenomicsstrategytopredictpotentialdrugtargetsinthemetazoanpathogenschistosomamansoni AT oellienfrank comparativechemogenomicsstrategytopredictpotentialdrugtargetsinthemetazoanpathogenschistosomamansoni AT marhoferrichardj comparativechemogenomicsstrategytopredictpotentialdrugtargetsinthemetazoanpathogenschistosomamansoni AT braschisimon comparativechemogenomicsstrategytopredictpotentialdrugtargetsinthemetazoanpathogenschistosomamansoni AT oliveiraguilherme comparativechemogenomicsstrategytopredictpotentialdrugtargetsinthemetazoanpathogenschistosomamansoni AT mckerrowjamesh comparativechemogenomicsstrategytopredictpotentialdrugtargetsinthemetazoanpathogenschistosomamansoni AT selzerpaulm comparativechemogenomicsstrategytopredictpotentialdrugtargetsinthemetazoanpathogenschistosomamansoni |